JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSS, C. R.
Right arrow Articles by FARAH, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSS, C. R.
Right arrow Articles by FARAH, A. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 167, Issue 2, 235-242, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


ATTEMPTS TO LABEL THE RENAL CARRIER FOR ORGANIC BASES WITH DIBENAMINE

CHARLES R. ROSS 1, NESS I. PESSAH 1, and ALFRED E. FARAH 1

1 Department of Pharmacology, State University of New York, Upstate Medical Center, Syracuse, New York

The technique of substrate protection was utilized to block the specific binding of Dibenamine. This enabled us to subsequently label the renal carrier of an organic base, N-methylnicotinamide. Renal cortex slices incubated with Dibenamine in the presence of various organic bases were protected against the inhibitory effects of Dibenamine. The extent of this protection depended upon the concentration of Dibenamine used. The inhibitory effects of Dibenamine could be prevented by the addition of sodium thiosulfate to the incubation medium; however, sodium thiosulfate was ineffective once Dibenamine had reacted with the slice. This confirms that the formation of the cyclic intermediate is necessary for the renal binding of Dibenamine. Experiments in which slices were exposed to 1) unlabeled Dibenamine or 2) unlabeled Dibenamine and tetraethylammonium or N-methylnicotinamide, then washed and exposed to Dibenamine-C14, washed a second time and finally fractioned into soluble, lipid and protein fractions, showed that only the protein fraction was protected by tetraethylammonium or N-methylnicotinamide. We conclude that the protein fraction contains a carrier-like protein. We have further concluded that the use of low concentrations of Dibenamine and short exposure times may facilitate the isolation of the carrier.

Submitted on September 30, 1968
Accepted on February 26, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.